评估将产前糖皮质激素扩展至晚期早产期的潜在影响
该队列研究利用2012年1月1日至2016年3月31日华盛顿州12个中心参与产科临床结局评估项目的单胎分娩病历数据,回顾2016年指南发布前的产前糖皮质激素使用情况,并按2016年指南标准将晚期早产(34+0至36+6周)分为潜在符合与不符合组,比较新生儿并发症发生率。
要点
- 早期早产(23+0至33+6周)中21.8%(226/1034)错过了产前糖皮质激素使用机会。
- 接受产前糖皮质激素者中32.2%(614/1908)在足月分娩;晚期早产占早产的74%(n=2942)。
- 晚期早产中80%(n=2363)潜在符合产前糖皮质激素条件,其中60%(n=1411)在36周分娩。
核心结论
- 需仔细考虑哪些妊娠应接受晚期早产产前糖皮质激素以及如何识别这些妊娠,以优化获益并减轻该干预的潜在风险。
研究设计与样本
- 队列研究,使用2012年1月1日至2016年3月31日华盛顿州12个参与产科临床结局评估项目(产科质量改进项目)中心的单胎分娩病历摘录数据。
- 排除分娩孕周缺失、胎儿畸形或产前死亡妊娠;评估2016年指南发布前产前糖皮质激素使用情况。
主要发现
- 早期早产(23+0至33+6周)中21.8%(226/1034)错过产前糖皮质激素机会;接受产前糖皮质激素者中32.2%(614/1908)足月分娩。
- 早产中74%(n=2942)为晚期早产;晚期早产中80%(n=2363)潜在符合产前糖皮质激素条件,其中60%(n=1411)在36周分娩。
- 34和35周分娩新生儿呼吸系统并发症发生率在潜在符合晚期早产产前糖皮质激素组高于不符合组。
- 36周分娩者中,呼吸系统并发症患病率按潜在符合产前糖皮质激素条件未检测到差异;潜在符合组较不符合组新生儿重症监护室入住风险更低(P < .001)。
- 晚期早产潜在符合产前糖皮质激素条件者中,新生儿呼吸系统并发症超过三分之二(69%;171/248)发生于34-35周分娩者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In 2016, guidance statements were issued by the Society for Maternal-Fetal Medicine and the American Congress of Obstetricians and Gynecologists about extending antenatal steroid use to selected late preterm singleton pregnancies. OBJECTIVE: We sought to review antenatal steroid use prior to the 2016 guidance statements and assess the potential impact of these. STUDY DESIGN: This cohort study used chart-abstracted data from singleton deliveries from Jan. 1, 2012, through March 31, 2016, at 12 centers participating in the Obstetrics Clinical Outcomes Assessment Program, a quality initiative in Washington State. Pregnancies with missing gestation at delivery, fetal anomalies, or antepartum demise were excluded. Antenatal steroid use prior to the 2016 guidance was evaluated based on the percentage of early preterm deliveries (23+0-33+6 weeks) and the percentage of all pregnancies that received antenatal steroids. Newborn complication rates were calculated for late preterm deliveries (34+0+0-36+6 weeks), grouped by whether they would be potentially eligible or ineligible for antenatal steroids based on the 2016 guidance statements. RESULTS: The opportunity for antenatal steroids was missed in 21.8% (226/1034) of early preterm deliveries and of all those who received antenatal steroids, 32.2% (614/1908) delivered at term. Of preterm deliveries, 74% (n = 2942) were in the late preterm period. In all, 80% (n = 2363) of late preterm deliveries were potentially eligible for antenatal steroids and 60% of these (n = 1411) delivered at 36 weeks. The rate of respiratory complications in newborns delivering at 34 and 35 weeks was higher in the group potentially eligible for late preterm antenatal steroids compared to those in the ineligible group. Of those delivering at 36 weeks, no differences were detected in prevalence of respiratory complications by potential eligibility for antenatal steroids; however, compared with the ineligible group, those potentially eligible had a lower risk of neonatal intensive care unit admission (P < .001). More than two thirds (69%; 171/248) of newborn respiratory complications among late preterm deliveries potentially eligible for antenatal steroids occurred in those delivering at 34-35 weeks. The highest rate of respiratory complications was in those ineligible for antenatal steroids due to prepregnancy diabetes or chorioamnionitis, regardless of gestational age at delivery. CONCLUSION: Careful consideration of which pregnancies should receive late preterm antenatal steroids and how to identify these pregnancies is important to optimize benefits and mitigate potential risks of this intervention.
引用
- Souter V, Kauffman E, Marshall AJ, et al. Assessing the potential impact of extending antenatal steroids to the late preterm period. Am J Obstet Gynecol. 2017. PMID: 28455087. doi:10.1016/j.ajog.2017.04.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。